Displaying 1 - 1 of 1
| Active Ingredient | BLEOMYCIN SULPHATE |
| Therapeutic Class | ANTINEOPLASTICS |
| Indications | Squamous cell carcinomas. |
| Caution | Extravasation, thromboembolism, nausea, vomiting,stomatitis, fever and chills, alopecia, pulmonary fibrosis. |
| Dose Range |
i.v. i.m: 15 000 IU.3 times a week, or 30 000 IU. Twice a week in combination regimens. This may be repeated, at 3 to 4 weeks intervals, up to a total cumulative dose of 500 000 IU. Dose and total cumulative dose should be reduced in those ov |
| Drug Interactions | |
| Pregnancy | Bleomycin sulfate can cause fetal toxicity when administered to pregnant women. More ... |
| Breast Feeding | Discontinue breastfeeding. |